-
2 months ago | 
outsourcedpharma.com | Louis Garguilo |Emerging trends |Bikash Chatterjee |Pharmatech Associates
Are you attending World ADC London this year? On March 4th, don't miss our presentation on "Technical Excellence in Development and Manufacturing of Bioconjugates". Visit booth #10 to meet our team and discover how we can accelerate your ADC, bioconjugate, or small molecule conjugate program. Request a meeting to discuss your needs with our experts and discover how we can support you with our 15+ years of experience and leading expertise in contract development and manufacturing.
-
2 months ago | 
outsourcedpharma.com | Bikash Chatterjee |Pharmatech Associates |Louis Garguilo
By Bikash Chatterjee, CEO, Pharmatech Associates
The biopharma industry’s clinical pipeline is reaching its largest and most diverse in history.
-
Sep 20, 2024 | 
outsourcedpharma.com | Louis Garguilo |Richard Steiner |Pharmatech Associates
Webinar: Enabled Form Selection for Oral Drug Products Using a Combination of In-Silico Modeling and In-Vitro MeasurementsThis webinar highlights the use of PBPK modeling software like GastroPlus® to simulate drug properties and interactions, reducing unnecessary testing. We'll cover solid form screening, formulation maps for amorphous solid dispersions, and criteria for salt screening, emphasizing how these tools can guide early drug form selection and enhance bioavailability.
-
Sep 4, 2024 | 
pharmaceuticalonline.com | Richard Steiner |Pharmatech Associates
By Richard Steiner, practice lead, Pharmatech Associates
In pharmaceutical continuous manufacturing (PCM), technical solutions ensuring critical quality attributes for content uniformity and unit dose exist for online, in-line, and at-line measurements.
-
Jun 19, 2024 | 
outsourcedpharma.com | Louis Garguilo |Fred A. Rowley |Bikash Chatterjee |Pharmatech Associates
Webinar: You Had Me at Flow: The Shift from Batch to Continuous A clear increase in continuous flow processes has emerged over the past decade thanks to the commercialization of preparative flow reactor units. This need for continuous flow manufacturing of active pharmaceutical ingredients and fine chemicals continues to grow as it offers important advantages over traditional batch manufacturing in terms of quality, safety, and sustainability of the overall process. Click here to learn more.
-
Jun 7, 2024 | 
cellandgene.com | Emily Marden |Kelly Kasulis Cho |Bikash Chatterjee |Pharmatech Associates
With additional cell therapy approvals on the horizon, a diverse array of products and platforms are needed to ensure safety and efficacy in manufacturing, increase speed to market, and decrease overall COGS. Join Cell & Gene Live for a digital discussion on the next generation of platforms and innovative technologies. Registration is free thanks to the support of Invetech. Hello Cell & Gene readers,I'm happy to bring you May's most-clicked articles.
-
May 31, 2024 | 
bioprocessonline.com | Brian Glass |Pharmatech Associates |Laura Walls
FOCUS ON PROCESS ENGINEERINGNovel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician — work he continues at Brigham and Women’s Hospital even as he builds Tome Biosciences, where he serves as President & CEO.
-
May 15, 2024 | 
cellandgene.com | Brian Glass |Pharmatech Associates
Genome editing holds immense promise for treating genetic diseases, but off-target effects remain a significant concern. To ensure the safety and efficacy of genome editing therapies, researchers are developing various strategies to reduce off-target effects. Register today for the next Cell & Gene Live. Attendance is free thanks to the support of Bio-Techne.
-
May 1, 2024 | 
cellandgene.com | Brian Glass |Pharmatech Associates
By Brian Glass, senior analytical consultant, Pharmatech Associates—a USP company
Plasmid DNA (pDNA) is a biomolecule used in vaccines and gene therapies for many types of diseases. One of the basic requirements for materials used in the production of drug products is to assure that the materials are well characterized with respect to purity and impurity profiles of the materials.
-
Mar 25, 2024 | 
cellandgene.com | Shalini Nagar |Bikash Chatterjee |Pharmatech Associates
Stem cells are the backbone of many allogeneic therapies and where they come from affects development and supply chain logistics, particularly cryopreservation. What temperatures are ideal to maintain product potency? How do you build a reliable cold chain? How do you work with existing infrastructure to allow for an “off-the-shelf” therapy? Don’t miss the next Cell & Gene Live digital event! Registration is free thanks to the support of Charter Medical and Bio-Techne.
